PHARMANET GROUP LIMITED (PNO)

name changed to Calidus Resources Limited

Calidus Resources Limited (formerly Pharmanet Group Limited) is pleased to advise that it successfully closed the oversubscribed offer to raise $7,875,000 via prospectus dated 5 May 2017 on the Closing Date of 1 June 2017.

The company releases the results of its meeting.

The company has lodged with the ASIC a prospectus for its offer to the public of 350 million shares at an issue price of $0.02 each and 87.5 million options at an issue price of $0.01 each to raise a total of $7.85 million.

The 2016 Annual General Meeting of the Company will be held at 108 Outram Street, West Perth, Western Australia on Tuesday, 30 May 2017 at 10.30am (WST).

The 2015 Annual General Meeting of the Company will be held at 108 Outram Street, West Perth, Western Australia on Tuesday, 30 May 2017 at 10.00am (WST).

The company has completed a placement to raise a total of $620,000. Strong demand confirms market support for the acquisition of the Warrawoona Gold Project. The targeted exploration program and drilling at Warrawoona will be accelerated.

The company lodges its Half Year Report 31 December 2016.

The company has entered into a conditional binding agreement to acquire 100% of Keras Gold Australia. Keras Australia controls the Warrawoona Gold Project. It is a wholly owned subsidiary of Keras Resources plc.

The final payment due under the terms of the DOCA has been received.Following payment of these funds, the DOCA was wholly effectuated on 7 March 2017. The Company has complied with all the terms of the DOCA and control of the Company has reverted to the recently appointed Board of Directors.

we understand that on or about this date the company consolidated its shares 1 for 300

The fully paid ordinary shares of the company have been consolidated on a 1 for 300 basis as approved by shareholders at the general meeting of shareholders. Notices to existing shareholders detailing their pre and post consolidation share holdings will be mailed on 22 February 2017.

The company provides an update regarding its consolidation - consolidation resolution was approved by shareholders.

The company releases the results of its general meeting.

Shareholders get 1 share for every 300 presently owned.

A General Meeting of the Company will be held at the offices of Palisade Business Consulting Pty Ltd, 22 Lindsay Street, Perth, Western Australia on Friday, 10 February 2017 at 10am (WST).

The company lodges its Annual Report and Financial Statements for FYE 30 June 2016.

The company lodges its Financial Statements for the Half Year Ended 31 Dec 2015.

The company lodges its Annual Report and Financial Statements for FYE 30 June 2015.

The company lodges its Financial Statements for Half Year Ended 31 December 2014.

The Deed Administrator and the Proponent have agreed to extend the due date of the DOCA to 30 May 2017. Other than the extension to the due date, the DOCA continues in full force and effect.

Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday 22 August 2016 will have its securities suspended from official quotation before the commencement of trading on Tuesday 23 August 2016. The company has not paid its annual listing fees in respect of the year ending 30 June 2017 but the securities are already suspended from official quotation.

The Company executed the DOCA with Otsana Pty Ltd on 21 June 2016. A copy of the DOCA has been lodged with the ASIC.

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the reconvened second meeting of creditors must be held be extended to 30 May 2016.

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the reconvened second meeting of creditors must be held be extended to 29 April 2016.

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the reconvened second meeting of creditors must be held be extended to 1 March 2016.

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the reconvened second meeting of creditors must be held be extended to 27 November 2015.

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the second meeting of creditors must be reconvened be extended to 27 October 2015.

The following entity (Pharmanet Group Limited) has not paid their annual listing fees in respect of the year ending 30 June 2016 but the securities are already suspended from official quotation. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm AEST on Monday 31 August 2015 will be removed from the official list with effect from the close of trading on Monday 31 August 2015

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the second meeting of creditors must be reconvened be extended to 25 September 2015.

At the second meeting of creditors of the Company held on 21 May 2015, creditors resolved that the meeting be adjourned for a period of not more than 45 business days.

Jack James of Palisade Business Consulting Pty Ltd was appointed Voluntary Administrator of the Company on 15 April 2015 pursuant to a resolution passed by the Board of Directors of the Company

advises that at the duly convened Annual General Meeting of the members of the company, all resolutions put to the members were passed.

the Annual General Meeting of the Company will be held in the John Worsfold Room, at Level 3, Gate 12, Roberts Road, Subiaco, Western Australia on Wednesday, the 26th day of November 2014 commencing at 10.30am WST

releases September 2014 Quarter Shareholder Update

The securities of Pharmanet Group Limited (the "Company") will be suspended from quotation from the commencement of trading tomorrow, Tuesday, 7 October 2014, at the request of the Company, pending the release of an announcement. Security Code: PNO PNOO

Deferred settlement trading of the securities of Pharmanet Group Limited (PNONA and PNOOB) (the "Company") will be suspended from quotation immediately due to the Company not proceeding with its non-renounceable offer. Security Codes: PNONA PNOOB

the suspension of trading in the securities of Pharmanet Group Limited (the "Company") will be lifted immediately, following receipt of an announcement in relation to a capital raising and placement

securities suspended pending an announcement

name changed from Pharmanet Online Limited